Glutamatergic and GABAergic reactivity and cognition in 22q11.2 deletion syndrome and healthy volunteers: A randomized double-blind 7-Tesla pharmacological MRS study.

MLA

Vingerhoets, Claudia, et al. “Glutamatergic and GABAergic Reactivity and Cognition in 22q11.2 Deletion Syndrome and Healthy Volunteers: A Randomized Double-Blind 7-Tesla Pharmacological MRS Study.” Journal of Psychopharmacology (Oxford, England), vol. 34, no. 8, Aug. 2020, pp. 856–63. EBSCOhost, https://doi.org/10.1177/0269881120922977.

APA

Vingerhoets, C., Tse, D. H., van Oudenaren, M., Hernaus, D., van Duin, E., Zinkstok, J., Ramaekers, J. G., Jansen, J. F., McAlonan, G., & van Amelsvoort, T. (2020). Glutamatergic and GABAergic reactivity and cognition in 22q11.2 deletion syndrome and healthy volunteers: A randomized double-blind 7-Tesla pharmacological MRS study. Journal of Psychopharmacology (Oxford, England), 34(8), 856–863. https://doi.org/10.1177/0269881120922977

Chicago

Vingerhoets, Claudia, Desmond Hy Tse, Mathilde van Oudenaren, Dennis Hernaus, Esther van Duin, Janneke Zinkstok, Johannes G Ramaekers, Jacobus Fa Jansen, Grainne McAlonan, and Therese van Amelsvoort. 2020. “Glutamatergic and GABAergic Reactivity and Cognition in 22q11.2 Deletion Syndrome and Healthy Volunteers: A Randomized Double-Blind 7-Tesla Pharmacological MRS Study.” Journal of Psychopharmacology (Oxford, England) 34 (8): 856–63. doi:10.1177/0269881120922977.